137 related articles for article (PubMed ID: 6961950)
1. Regulation of human natural killing by levamisole.
Shau H; Dawson JR
Cancer Immunol Immunother; 1982; 13(1):24-9. PubMed ID: 6961950
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
Bradley TP; Bonavida B
Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
Brahmi Z; Bray RA; Abrams SI
J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
[TBL] [Abstract][Full Text] [Related]
4. Effects of levamisole on human natural killer and killer cell activity and production of interferons.
Liberati M; Borden EC; McBain JA; Raubertas R
Immunopharmacology; 1982 Oct; 5(1):11-8. PubMed ID: 6182126
[TBL] [Abstract][Full Text] [Related]
5. Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole.
Son K; Kew M; Rabson AR
Cancer; 1982 Dec; 50(12):2820-5. PubMed ID: 6182983
[TBL] [Abstract][Full Text] [Related]
6. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
Xiao J; Brahmi Z
Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
[TBL] [Abstract][Full Text] [Related]
7. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
Helfand SL; Werkmeister J; Roder JC
J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
9. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
Thiele DL; Lipsky PE
J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
[TBL] [Abstract][Full Text] [Related]
10. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
11. Human natural killing against ovarian carcinoma.
Shau H; Koren HS; Dawson JR
Br J Cancer; 1983 May; 47(5):687-95. PubMed ID: 6573908
[TBL] [Abstract][Full Text] [Related]
12. Direct induction of lymphocyte killing by calcium ionophore and phorbol ester treatment.
Mikael J; Janet N; Maj-Britt A
Cell Immunol; 1987 Mar; 105(1):23-32. PubMed ID: 3102081
[TBL] [Abstract][Full Text] [Related]
13. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
Kiyohara T; Dennis JW; Boegman RJ; Roder JC
J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
[TBL] [Abstract][Full Text] [Related]
14. Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Mani R; Rajgolikar G; Nunes J; Zapolnik K; Wasmuth R; Mo X; Byrd JC; Lee DA; Muthusamy N; Vasu S
Cytotherapy; 2020 Jul; 22(7):369-376. PubMed ID: 32303428
[TBL] [Abstract][Full Text] [Related]
15. Immune capability of rats with colorectal carcinoma treated by resection with or without 5-fluorouracil or levamisole.
House AK; Maley MA
J Surg Oncol; 1984 Nov; 27(3):172-8. PubMed ID: 6333555
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of bovine lymphocytes after treatment with lymphokines.
Campos M; Rossi CR
Am J Vet Res; 1986 Jul; 47(7):1524-8. PubMed ID: 3488701
[TBL] [Abstract][Full Text] [Related]
17. Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.
Shau H; Golub SH
J Immunol; 1985 Feb; 134(2):1136-41. PubMed ID: 3871208
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
19. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
Moroz C; Madgar I; Twig S; Lindner A; Many M
Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
